Recent studies have strengthened links between the pathogenesis of Alzheimer's disease (AD) and processing of beta-amyloid precursor protein (APP) leading to formation of amyloid beta-peptide (Abeta), especially increased levels of Abeta(1-42). A key element missing in this """"""""amyloid hypothesis"""""""" of neuronal degeneration is the means by which low levels of Abeta perturb cellular functions; we hypothesize that Abeta interaction with cellular cofactors mediates these early events. The receptor RAGE is a multi-ligand member of the immunoglobin superfamily of cell surface molecules, and binds Abeta, showing highest affinity for beta-sheet fibrils. Cells in culture expressing in vivo studies demonstrate RAGE interaction with amyloid. Whereas cellular perturbation consequent to Abeta-RAGE interaction causes sustained activation in microglia, we predict that, over time, similar activation in neurons predisposes to several cell dysfunction and death. In AD brain, RAGE is expressed at high levels in neurons and activated microglia proximal to Abeta deposits, and increased levels of RAGE are also seen in transgenic (Tg) mice over-expressing mutant human (h) APP. We hypothesize that increased RAGE in AD brain provides a pivotal cofactor promoting neuronal stress, as reflected by neuronal dysfunction at the earliest stages of AD. i.e., before high concentration of Abeta are achieved. Our project utilizes Tg mice with targeted with over-expression of RAGE in neurons (aim 1), microglia (aim 2) or both cell types (aim 3) to determine whether they display enhanced neuronal stress in a Abeta- rich environment, the latter provided by over-expression of mutant betaAPP on the PDGF B chain promoter (neuropathologic, electrophysiologic, biochemical and behavioral endpoints will be studied). Our pilot studies with Tg PD-RAGE/hAPP mice show increased expression of cell stress markers, Interleukin 6 and Macrophage Colony Stimulating Factor, and NF-kappaB activation, compared with singly- transgenic mice. In view of the close relationship between ischemic episodes and the clinical course of AD/amyloid angiopathy, the response of these mice to ischemic stress will also be evaluated. Project 1 will work closely with Projects 2-4 and will obtain technical assistance from Core B. Collaborative interactions include: exchange of reagents/techniques related to RAGE biology (Project 2), evaluation of cellular stress (Projects 3-4), and neuropathologic analysis (Core B).

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
3P01AG017490-02S1
Application #
6493032
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Juranek, Judyta K; Daffu, Gurdip K; Geddis, Matthew S et al. (2016) Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. Front Cell Neurosci 10:117
Carlson, Emily A; Marquez, Rebecca T; Du, Fang et al. (2015) Overexpression of 17?-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death. BMC Cancer 15:166
Du, Heng; Guo, Lan; Wu, Xiaoping et al. (2014) Cyclophilin D deficiency rescues A?-impaired PKA/CREB signaling and alleviates synaptic degeneration. Biochim Biophys Acta 1842:2517-27
Juranek, Judyta K; Geddis, Matthew S; Rosario, Rosa et al. (2013) Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE. Eur J Neurosci 38:3159-68
Borger, Eva; Aitken, Laura; Du, Heng et al. (2013) Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? Curr Alzheimer Res 10:21-9
Juranek, Judyta K; Geddis, Matthew S; Song, Fei et al. (2013) RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes 62:931-43
Fang, Fang; Chen, Xiaochun; Huang, Tianwen et al. (2012) Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochim Biophys Acta 1822:286-92
Du, Heng; Guo, Lan; Yan, Shirley ShiDu (2012) Synaptic mitochondrial pathology in Alzheimer's disease. Antioxid Redox Signal 16:1467-75
Huang, Tianwen; Fang, Fang; Chen, Limin et al. (2012) Ginsenoside Rg1 attenuates oligomeric A?(1-42)-induced mitochondrial dysfunction. Curr Alzheimer Res 9:388-95
Carnevale, Daniela; Mascio, Giada; D'Andrea, Ivana et al. (2012) Hypertension induces brain ?-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension 60:188-97

Showing the most recent 10 out of 68 publications